The nasal spray appeared to alter immune signaling between Treg cells and microglia, shifting the immune response from ...

Now a nasal spray developed by Italian researchers to ... explaining how these enzymes then go on to alter cognitive function and the abnormal accumulations of protein clumps.

In a move to expand its portfolio beyond antibiotics, Paratek Pharmaceuticals has bought out Optinose and its chronic ...

Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...